Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nebulized antibiotic therapy: the evidence.

S P Conway1

  • 1Cystic Fibrosis Services, St James' Hospital, Leeds, UK. steven.conway@leeds.nhs.uk

Chronic Respiratory Disease
|November 11, 2005
PubMed
Summary

Nebulized antibiotics effectively treat chronic Pseudomonas aeruginosa infections and aid eradication of early infections, improving respiratory function and reducing exacerbations. Long-term use shows clinical benefit without significant impact on bacterial resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2013
Same author

Enteral tube feeding in adults with cystic fibrosis; patient choice and impact on long term outcomes.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2013
Same author

Patient indicators of a pulmonary exacerbation: preliminary reports from school aged children map onto those of adults.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2011
Same author

Diseases of infection.

Archives of disease in childhood·2010
Same author

Cystic fibrosis co-existing with trisomy 21.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2010
Same author

Serum tobramycin levels following delivery of tobramycin (Tobi) via eFlow advanced nebuliser in children with cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2010

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Pharmacology

Background:

  • Pseudomonas aeruginosa is a significant pathogen in chronic respiratory infections.
  • Nebulized antibiotics offer targeted delivery to the respiratory tract.
  • Established use in Europe and increasing adoption in North America.

Purpose of the Study:

  • To review the efficacy and safety of nebulized antibiotic therapy.
  • To assess its role in chronic and early Pseudomonas aeruginosa infections.
  • To evaluate its impact on respiratory function and exacerbations.

Main Methods:

  • Review of meta-analyses and large-scale randomized control trials.
  • Analysis of studies on nebulized colistin, tobramycin, and tobramycin solution for inhalation (TSI).
  • Assessment of comparative efficacy against intravenous antibiotics.

Main Results:

  • Nebulized antibiotics improve respiratory function and reduce hospital admissions and exacerbations.
  • Significant reduction in Pseudomonas aeruginosa load in respiratory tract infections.
  • Successful eradication of early infections reported with specific regimens.
  • No demonstrated advantage over intravenous antibiotics for acute exacerbations.

Conclusions:

  • Nebulized antibiotic therapy is effective for chronic and early Pseudomonas aeruginosa infections.
  • It offers improved outcomes without significant clinical impact on bacterial resistance.
  • Patient assessment for bronchospasm is crucial before and during long-term therapy.

Related Experiment Videos